Continentalic acid is primarily used in research settings due to its biological activity. It has shown potential anti-inflammatory and neuroprotective properties, making it a compound of interest in the development of therapies for neurological disorders such as Alzheimer's and Parkinson's disease. Studies suggest it may modulate signaling pathways involved in oxidative stress and neuronal cell death. Additionally, it has been investigated for its role in inhibiting certain enzymes linked to chronic inflammatory conditions. Its natural origin and bioactivity also make it a candidate for use in nutraceuticals and cosmeceuticals aimed at cellular protection and anti-aging.